Clinical trials
Menstruation Disturbances trials with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
40 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 2 |
| 2006 | 1 |
| 2012 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 3 |
| 2021 | 2 |
| 2022 | 4 |
| 2023 | 6 |
| 2024 | 6 |
| 2025 | 5 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 19 |
| Unknown status | 9 |
| Recruiting | 5 |
| Not yet recruiting | 3 |
| Active, not recruiting | 2 |
| Withdrawn | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Penn State University | 3 |
| Riphah International University | 2 |
| Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 1 |
| Asian Institute of Gastroenterology, India | 1 |
| Bandırma Onyedi Eylül University | 1 |
| Bulent Ecevit University | 1 |
| Cairo University | 1 |
| Catholic University of the Sacred Heart | 1 |
| Chang Gung Memorial Hospital | 1 |
| Charite University, Berlin, Germany | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Menstruation Disturbances | 40 |
| Dysmenorrhea | 10 |
| Polycystic Ovary Syndrome | 10 |
| Endometriosis | 3 |
| Hirsutism | 3 |
| Amenorrhea | 2 |
| Anxiety Disorders | 2 |
| Hyperandrogenism | 2 |
| Infertility | 2 |
| Leiomyoma | 2 |
Trials
Showing 26 to 40 of 40. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.